Figure 8From: Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125 Immunohistochemical evaluation of LHRH receptor expression: positive cytoplasmic staining reaction (a) and negative staining reaction (b) in triple negative human breast cancer samples (20×). Back to article page